Our client came to us as a bulk manufacturer of an important Active Pharmaceutical Ingredient (API). A close-call event at their plant had prompted them to review their synthesis procedures and equipment and process safety. MAC SciTech were able to assess their process and redesign a reactor system capable of producing their product in a much smaller and safer continuous flow reactor system. MAC SciTech were involved in the process from design to prototyping of the reactor components and control systems revolutionising their synthetic procedure, improving safety and reducing overall reactor volumes. The project included in-house chemical analysis, organic chemical synthesis and process control.